Dxcover

Dxcover is a clinical-stage liquid biopsy company developing tests for the early detection of multiple cancers. The company is pioneering the use of infrared spectroscopy with circulating pan-atomic biomarkers for the early detection and identification of cancer. It has generated compelling clinical data demonstrating high-accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, UK, and is expanding its operations in the United States.